Clinical Trial

Implementation for Heart Failure Therapies Post-discharge Followed by CardiOSIgnal at HOME

Study acronym: COSI-HOME
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 25, 2025 (before its estimated January 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
CardioSignal technology (mechanocardiography) could enable home follow-up after admission for acute heart failure, thus improving guidline-directed medical therapies for heart failure dose escalation while reducing the logistical constraints and stress associated with frequent hospital visits. The intended purpose is to detect signs of HF in adults (aged 18 years or older and \< 85 years)
Trial Details
NCT Number NCT06944405
Lead Sponsor Precordior Ltd
Collaborators: Eshmoun Clinical Research Center, Sahloul Hospital of Sousse
Conditions Heart Failure
Enrollment 65 participants
Start Date 2025-05-10
Primary Completion 2026-01-31 (estimated)
Study Completion 2026-01-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-25